Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (21)

2023

  1. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 4949-4963

2022

  1. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

  2. Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

    Brain, Vol. 145, Núm. 6, pp. 2092-2107

2021

  1. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  2. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats

    Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431

  3. RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases

    Neuro-Oncology Advances, Vol. 2, Núm. 1

  4. [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 11, pp. 2602-2612

2019

  1. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease

    Neurobiology of Aging, Vol. 75, pp. 126-135

2018

  1. Using Kinect to classify Parkinson's disease stages related to severity of gait impairment

    BMC Bioinformatics, Vol. 19, Núm. 1

2017

  1. Enhanced Missing Proteins Detection in NCI60 Cell Lines Using an Integrative Search Engine Approach

    Journal of Proteome Research, Vol. 16, Núm. 12, pp. 4374-4390

2016

  1. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

  2. Genetic Mutation Analysis of Parkinson’s Disease Patients Using Multigene Next-Generation Sequencing Panels

    Molecular Diagnosis and Therapy, Vol. 20, Núm. 5, pp. 481-491

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

  2. Cambios en la sustancia gris en pacientes con enfermedad de parkinson y bloqueos de la marcha

    Revista de Neurologia

2014

  1. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

    Parkinsonism and Related Disorders, Vol. 20, Núm. 10, pp. 1097-1100

  2. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes

    Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2657.e13-2657.e19

  3. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

    Movement Disorders, Vol. 29, Núm. 6, pp. 750-755

2009

  1. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways

    Multiple Sclerosis, Vol. 15, Núm. 3, pp. 337-344

  2. Fractal dimension analysis of grey matter in multiple sclerosis

    Journal of the Neurological Sciences, Vol. 282, Núm. 1-2, pp. 67-71